CDK5 and Alzheimer disease: Until now, one study showed that CDK5 level in CSF from AD patients was decreased than compared with that from control subjects (Oláh et al., 2015), while two autopsy studies observed that CDK5 level was increased in the brains of AD patients compared with that of control (Lee et al., 1999; Sultana and Butterfield, 2007).